Project Grant R01DA066104
Award Date 9/1/26
Completion Date 6/30/31
Dollars Obligated $702K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $858,000 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on substances, behaviors, and outcomes of adolescent reporting to a statewide technology-facilitated reporting system. The research will use mixed natural language processing, statistical, and qualitative methods to analyze tip-level data across six years and conduct qualitative interviews with school...
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $194,298 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) for a K01 Mentored Research Scientist Development Award supporting Dr. Daniel Lee's research on cannabis use and assault injury risk in youth. The award funds a pilot study investigating near-term risk and protective factors linking cannabis use to violence among emerging adults (ages 18–25) with and without assault...
- The National Institute on Drug Abuse awarded $1.403928 million to the Regents of the University of Michigan on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a remote behavioral economics-based intervention for cannabis use disorder delivered via synchronous videoconferencing. The research addresses the gap between prevalence of cannabis use disorder and treatment access: approximately 22 percent of cannabis users develop the condition, yet...
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $325,904 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop real-time machine learning methods for constructing and perturbing stimulus-shaped neural manifolds. The project deliverables span three aims: developing real-time dimensionality reduction algorithms to construct neural manifolds shaped by external stimulus information; designing probabilistic models for...
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $386,301 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate axonal mechanisms regulating dopamine release in the striatum. The research uses direct recording of axonal voltage to examine how dopaminergic axons control dopamine release, with specific focus on the role of striatal cholinergic interneurons in modulating dopamine availability. The work addresses a gap...
- The National Institute on Drug Abuse awarded Loyola University of Chicago Health Sciences Campus $551,926 on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a large-scale longitudinal epidemiological study of polysubstance use and associated health outcomes. The recipient will leverage the Oracle EHR Real-World Data database, comprising 1.9 billion encounters from 113 million patients across 700 U.S. hospitals and clinics, to conduct four primary...
- The National Institute on Drug Abuse awarded New York University $103,607 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct dissertation research on polysubstance use patterns and their associations with methadone maintenance treatment receipt and discontinuation among people who use drugs in New York State. The research uses a mixed-methods approach guided by the Social Ecological Model to identify latent polysubstance use patterns through urine...
- The National Institute on Drug Abuse awarded Michigan State University (doing business as Henry Ford Health+Michigan State University Health Sciences) $295,896 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate epigenetic risk scoring tools for polysubstance use and comorbidity assessment in people with HIV. The project addresses the clinical gap in objective measurement of polysubstance use among people with HIV, where current screening...
- The National Institute on Drug Abuse awarded The McLean Hospital Corporation $736,811 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal cohort study of opioid use disorder. The project characterizes the long-term course of opioid use disorder through remote follow-up of 550 adults with opioid use disorder recruited from sites across the United States. The study employs monthly patient-reported outcomes and annual...
- The National Institute on Drug Abuse awarded $1,843,025 to the Regents of the University of Michigan on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a web-delivered screening, brief intervention, and referral to treatment or prevention program called Health Check-Up for Expectant Moms Plus (HCEM+). The award funds a randomized controlled trial enrolling 250 high-risk rural pregnant women to evaluate the efficacy of HCEM+ in reducing...